Syneos Health Signs Agreement with Pacific Clinical Research Network to Support Clinical Trials in New Zealand
December 23, 2024
MORRISVILLE, N.C., December 23, 2024 - Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, has signed an agreement with Pacific Clinical Research Network (PCRN).The agreement expands the Company’s clinical trial capabilities across a broad range of therapeutic areas in New Zealand.
Pacific Clinical Research Network now becomes part of the Syneos Health Catalyst and Site Network Partnerships program, including 110+ clinical sites and 60+ commercial site networks. As part of the Site Network Partnerships program, PCRN joins a select set of high-performing investigative site networks strategically aligned to Syneos Health’s clinical studies. Site Network Partnerships provide enhanced patient access, improved efficiencies, specialized expertise and access to diverse patient populations across all therapeutic areas and phases.
“We are excited to begin this strategic collaboration with Pacific Clinical Research Network” said David Gebbo, Director of Clinical Operations, Syneos Health. “The work with PCRN supports our strong focus on delivering clinical trial programs, achieving consistent delivery and quality, and executing fit-for-purpose solutions that address unique and complex clinical research needs. Importantly, this collaboration accelerates our goal to bring life-changing therapies to patients with speed and quality.”
PCRN is New Zealand’s largest network of clinical trial sites with nine sites spread across the country and was established in 2021 through a merger of Lakeland Clinical Trials Group and Southern Clinical Trials Group with the former being in operation since 2002. In 2023, PCRN expanded its offerings and has a brand-new purpose-built Multi Phase Unit in Auckland which now complements its late phase sites.
Over the past 22 years, PCRN has significantly contributed to the evolution of clinical trials in New Zealand. With a participant-first focus, PCRN conducts clinical trials across all phases and a diverse range of therapeutic areas, offering a streamlined, integrated nationwide partner network.
"Joining forces as a Syneos Health Catalyst and Site Network Partner enhances the collaboration and trust we've established with Syneos Health, allowing us to deliver high-quality clinical trials with a strong focus on participant safety," said Rosie McKellar, CEO of PCRN. "We are excited to deepen our work together, which complements the company’s extensive capabilities across early and late-phase trials and amplifies our shared commitment to innovation and excellence in clinical research."
About Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.
Press/Media Contact:
Meg Byers
Director, External Communications
+1 607 215 1330[email protected]
